-
Tomada, G., Jacova, C., Masini, F., & Menesini, E. (1985). [“The relationship between the child and the object in symbolic play”]. Eta Evolutiva, 21, 89-94.
-
Clark, C., Jacova, C., Klonoff, H., Kremer, B., Hayden, M., & Paty, D. (1997). “Pathological associations and dissociations of functional systems in Multiple Sclerosis and Huntington’s Disease. Journal of Clinical and Experimental Neuropsychology, 19 (1), 63-76.
-
Kremer, B., Clark, C., Elmqvist, E., Raymond, L., Graf, P., Jacova, C., Mezei, M., Hardy, M., Snow, B., Martin, W., & Hayden, M. (1999). Influence of lamotrigine on progression of early Huntington disease: a randomized clinical trial. Neurology, 53 (5), 1000-11.
-
Thorpe, C. M., Jacova, C., & Wilkie, D. M. (2004). Some pitfalls in measuring memory in animals. Neuroscience and Biobehavioral Reviews, 28 (7), 711-8.
-
Feldman, H, & Jacova, C. (2005). Mild Cognitive Impairment. American Journal of Geriatric Psychiatry, 13, 645-655.
-
Feldman, H & Jacova C. (2005). Assessing Mental Status in Dementia: The Behavioural Neurology Assessment -–Right Time? Right Place? The Canadian Journal of Neurological Sciences, 32(2), 138-139.
-
Burns, A., O’Brien, J., British Association of Psychopharmacology (BAP) Consensus Group; Auriacombe, S., Ballard, C., Broich, K., Bullock, R., Feldman, H., Ford, G., Knapp, M., McCaddon, A., Iliffe, S., Jacova, C., Jones, R., Lennon, S., McKeith, I., Orgogozo, J.M., Purandare, N., Richardson, M., Ritchie, C., Thomas, A., Warner, J., Wilcock, G., Wilkinson, D. (2006). Clinical practice with anti-dementia drugs: a consensus statement from British Association of Psychopharmacology. Journal of Psychopharmacology, 20 (6), 732-755.
-
Dubois, B., Feldman, H., Jacova, C., DeKosky, S., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., Meguro, K., O'Brien, J., Pasquier, F., Robert, P., Rossor, M., Salloway, S., Stern, Y., Visser, P.J., and Scheltens, P. Research criteria for the diagnosis of Alzheimer's disease: Revising the NINCDS-ADRDA criteria. Lancet Neurology 2007 Aug; 6 (8): 734-46.
-
Jacova, C., Kertesz, A., Blair, M., Fisk, J. and Feldman, H.H. Neuropsychological testing and assessment for dementia. Alzheimer's & Dementia 2007; 3: 299-317.
-
Feldman, H. & Jacova, C. Primary prevention and delay of onset of AD/dementia. Canadian Journal of Neurological Sciences 2007; 34 Suppl 1: S84-9.
-
Peters, K.P., Hogan, D., Black, S., Gauthier, S., Rockwood, K., Loy-English, I., Hsiung, G.-Y.R., Jacova, C. & Feldman H.H. Neuropsychiatric symptom clusters and functional disability in Cognitively-Impaired-Not-Demented Individuals. American Journal of Geriatric Psychiatry 2008 Feb; 16 (2): 136-44.
-
Feldman, H., Jacova, C., Robillard, A., Garcia, A., Chow, T., Borrie, M., Schipper, H.M., Blair, M. and Kertesz, A. The diagnosis of dementia. Canadian Medical Association Journal 2008 March 25; 178 (7): 825-36.
-
Hsiung, G.-Y.R., Alipour, S., Jacova, C., Grand, J. and Feldman, H. Transitions from Cognitive Impairment Not Dementia (CIND) to Alzheimer’s Disease: An analysis of changes in functional abilities. Dementia and Geriatric Cognitive Disorders 2008; 25 (6): 483-90.
-
Jacova, C., Peters, K.R., Wong, E. , Beattie, B.L., Foti, D., Scheltens, P., Li, D. & Feldman, H.H. Cognitive-Impairment-No-Dementia (CIND) - Neuropsychological and neuroimaging characterization of an amnestic subtype. Dementia and Geriatric Cognitive Disorders 2008; 25 (3): 238-247.
-
Feldman, H., Jacova, C. Predicting response to acetylcholinesterase inhibitor treatment in Alzheimer disease: Has the time come? Nat Clin Pract Neurol 2009: Mar; 5 (3): 128-9.
-
Woodward, M., Jacova, C., Black, S., Kertesz, A., Mackenzie, I., Feldman, H. Differentiating the frontal variant of Alzheimer Disease. International Journal of Geriatric Psychiatry 2010: 25(7); 732-8.
-
Liu-Ambrose, T, Eng, JJ, Boyd LA, Jacova C, Davis JC, Bryan S, Lee P, Brasher P, Hsiung GY. Promotion of the mind through exercise (PROMoTE): a proof-of-concept randomized controlled trial of aerobic exercise in older adults with vascular cognitive impairment. BMC Neurol 2010: Feb 17; 10-14.
-
Dubois B, Feldman H, Jacova C, Cummings J, DeKosky ST, Barberger-Gateau P, Delacourte A, Frisoni G, Fox, NC, Galasko D, Gauthier S, Hampel H, Jicha GA, Kenichi M, O’Brien J, Pasquier F, Robert P, Rossor M, Salloway S, Sarazin M, de Souza LC, Stern Y, Visser PJ, Scheltens P. Revising the definition of Alzheimer’s Disease: A new lexicon. Lancet Neurology 2010; 9 (11): 1118-27.
-
Woodward M, Hsiung GYR, Feldman H, Jacova C, Mackenzie IR. Multiple pathologies in dementia are common. European Geriatric Medicine 2010: 1 (5): 259-265.
-
Sepehry AA, Lee PE, Hsiung GY, Jacova C. Stay the course – is it justified? Lancet 2012; 379 (9812): 220.
-
Brehmer, M, McGrenere J, Tang, C, Jacova, C. Effects of interruptions on older adults' computerized cognitive test performance. ACM Conference on Human Factors in Computing Systems (CHI) 2012 (In press).
-
Wang BW, Lu E, Assaly M, Jacova C, Lee PE, Mackenzie IR, Beattie BL, Hsiung GYR. Mixed pathology is common in Alzheimer patients in clinical trials. Canadian Journal of Neurosciences 2012 (In press).
-
Sepehry, A.A., Lee, P.E., Hsiung, G-Y. R., Beattie, B.L., Jacova, C. Effect of SSRIs in Alzheimer Disease with comorbid depression: A meta-analysis of cognitive and depression outcomes. Drugs & Aging 2012 (In press).
-
Hsiung, G.-Y. R., Alipour, S., Jacova C., Donald, A., & Feldman, H. (2006). Functional impairment associated with progression from CIND to Alzheimer’s Disease. Research and Practice in Alzheimer’s Disease, 11.
-
Jacova C., Hsiung, G-Y. R., & Feldman, H. (2006). Dropouts and refusals in observational studies: Lessons for prevention trials. Neurology, 67 (Suppl 3), S1-3.